Sumatriptan succinate and Cambia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Cambia (diclofenac potassium). Common drug interactions include influenza like illness among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Cambia. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Cambia?

Cambia has active ingredients of diclofenac potassium. eHealthMe is studying from 2,339 Cambia users. Check the latest studies of Cambia.

On Jul, 14, 2026

19 people who take Sumatriptan succinate and Cambia together, and have interactions are studied.

Sumatriptan succinate and Cambia drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Cambia, by gender? *:

female:

Influenza like illness
Irritability
Lethargy (tiredness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Photophobia (extreme sensitivity to light)
Rash
Abdominal discomfort
Adverse event
Back pain
Bruxism (habitual grinding of the teeth, typically during sleep)

male:

Death
Dermatitis allergic (inflammation of the skin due allergic reaction)
Drug ineffective
Stem cell transplant

What are the common drug interactions of Sumatriptan Succinate and Cambia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Affect lability (emotional incontinence)
Drug ineffective
Headache (pain in head)
Irritability
Lethargy (tiredness)
Pain
Photophobia (extreme sensitivity to light)
Rash
Abdominal discomfort
Adverse event

40-49:

Nerve block (the interruption of signals travelling along a nerve)
Pain in extremity
Stem cell transplant
Influenza like illness
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Death
Dermatitis allergic (inflammation of the skin due allergic reaction)
Drug ineffective
Injection site haemorrhage (bleeding from injection site)
Injection site urticaria (rash of round, red welts on the skin at injection site)

50-59:

Drug ineffective
Thrombosis (formation of a blood clot inside a blood vessel)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 26.32%
Drowsiness: 5 people, 26.32%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 15.79%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.26%
Migraine With Aura (headache with vision weakness): 1 person, 5.26%
Insomnia (sleeplessness): 1 person, 5.26%
Headache (pain in head): 1 person, 5.26%
Facial Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Cambia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously